Candriam SCA’s Enanta Pharmaceuticals ENTA Stock Holding History

Candriam SCA’s Portfolio ENTA Stock Details ENTA Fund Activity

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-40,507	Closed	-$1.51M	–	771
2023 Q1	$1.51M	Sell	40,507 -60,000	-60%	-$2.23M	0.01%	631
2022 Q4	$4.68M	Hold	100,507	–	–	0.03%	392
2022 Q3	$5.21M	Sell	100,507 -14,000	-12%	-$726K	0.04%	367
2022 Q2	$5.41M	Hold	114,507	–	–	0.04%	316
2022 Q1	$8.15M	Sell	114,507 -46,851	-29%	-$3.33M	0.06%	280
2021 Q4	$12.1M	Buy	+161,358	New	+$12.1M	0.08%	236
2021 Q2	–	Sell	-178,941	Closed	-$7.24M	–	909
2021 Q1	$7.24M	Hold	178,941	–	–	0.06%	311
2020 Q4	$7.53M	Buy	178,941 +114,907	+179%	+$4.84M	0.06%	319
2020 Q3	$2.93M	Buy	+64,034	New	+$2.93M	0.03%	440
2020 Q2	–	Sell	-110,139	Closed	-$6.65M	–	819
2020 Q1	$6.65M	Hold	110,139	–	–	0.07%	285
2019 Q4	$6.8M	Sell	110,139 -4,861	-4%	-$300K	0.07%	291
2019 Q3	$6.91M	Buy	115,000 +50,000	+77%	+$3M	0.09%	256
2019 Q2	$5.46M	Hold	65,000	–	–	0.07%	311
2019 Q1	$6.21M	Buy	65,000 +3,000	+5%	+$287K	0.08%	278
2018 Q4	$4.39M	Buy	+62,000	New	+$4.39M	0.07%	307
2018 Q3	–	Sell	-12,500	Closed	-$1.45M	–	820
2018 Q2	$1.45M	Sell	12,500 -12,000	-49%	-$1.39M	0.02%	542
2018 Q1	$1.98M	Sell	24,500 -43,500	-64%	-$3.52M	0.03%	484
2017 Q4	$3.99M	Sell	68,000 -157,000	-70%	-$9.21M	0.07%	313
2017 Q3	$10.5M	Sell	225,000 -85,000	-27%	-$3.98M	0.18%	152
2017 Q2	$11.2M	Sell	310,000 -46,000	-13%	-$1.66M	0.21%	129
2017 Q1	$11M	Buy	356,000 +120,000	+51%	+$3.7M	0.21%	135
2016 Q4	$7.91M	Sell	236,000 -6,000	-2%	-$201K	0.18%	143
2016 Q3	$6.44M	Buy	+242,000	New	+$6.44M	0.15%	158
2016 Q2	–	Sell	-162,000	Closed	-$4.73M	–	663
2016 Q1	$4.73M	Buy	162,000 +56,000	+53%	+$1.64M	0.12%	206
2015 Q4	$3.5M	Buy	+106,000	New	+$3.5M	0.09%	231
2015 Q3	–	Sell	-45,000	Closed	-$2.03M	–	629
2015 Q2	$2.03M	Buy	+45,000	New	+$2.03M	0.04%	363
2015 Q1	–	Sell	-35,000	Closed	-$1.78M	–	644
2014 Q4	$1.78M	Buy	+35,000	New	+$1.78M	0.04%	370